Articles published by Repare Therapeutics Inc.
Repare Therapeutics Announces Strategic Reprioritization to Focus on Broad Clinical Portfolio
August 28, 2024
Via Business Wire
Tickers
RPTX
Via Business Wire
Tickers
RPTX
Via Business Wire
Tickers
RPTX
Via Business Wire
Tickers
RPTX
Repare Therapeutics to Participate in Two Upcoming Investor Conferences
February 29, 2024
Via Business Wire
Tickers
RPTX
Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
February 28, 2024
Via Business Wire
Tickers
RPTX
Via Business Wire
Tickers
RPTX
Repare Therapeutics to Regain Global Rights to Camonsertib
February 12, 2024
Via Business Wire
Tickers
RPTX
Repare Therapeutics Announces Achievement of $40 Million Roche Clinical Milestone Payment
January 25, 2024
Via Business Wire
Tickers
RPTX
Repare Therapeutics Provides Corporate Update and Highlights Anticipated Key 2024 Milestones
January 08, 2024
Via Business Wire
Tickers
RPTX
Via Business Wire
Tickers
RPTX
Repare Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
November 09, 2023
Via Business Wire
Tickers
RPTX
Via Business Wire
Tickers
RPTX
Repare Therapeutics to Participate in Two Upcoming Investor Conferences
November 06, 2023
Via Business Wire
Tickers
RPTX
Via Business Wire
Tickers
RPTX
Repare Therapeutics to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference
September 06, 2023
Via Business Wire
Tickers
RPTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.